EL
ELAB.US PMGC Holdings Inc.
- Market cap
- USD 1.28M
- P/E
- -
- P/B
- 0.08x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is ELAB.US undervalued?
Graham numberThe Graham number of PMGC Holdings Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
PMGC Holdings Inc. fundamental analysis
No fundamental analysis for PMGC Holdings Inc. yet.
PMGC Holdings Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About PMGC Holdings Inc.
PMGC Holdings Inc., doing business as NorthStrive Holdings, Inc, a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on…
Full company profilePMGC Holdings Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
PMGC Holdings Inc. annual financial statements
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | - | 827.00 | 766K | 1.71M | 2.47M | 590K | 6.03M |
| Gross Profit | - | 739.00 | 447K | -554.00 | 1.80M | 74.8K | 1.04M |
| Operating Income | -222K | -785K | -1.79M | -1.14M | -1.87M | -7.38M | -12.5M |
| EBITDA | -1.07K | -782K | -1.79M | -1.13M | -3.27M | -7.27M | -11.5M |
| Net Income | -223K | -785K | -1.80M | -4.30M | -6.25M | -7.71M | - |
| EPS | -20 | -888 | -159 | -1,511 | -65,745 | -3,788 | - |
| Balance Sheet | |||||||
| Total Assets | 17.0K | 666K | 1.89M | 5.19M | 8.99M | 12.9M | 133M |
| Total Liabilities | 40.6K | 216K | 761K | 1.36M | 2.33M | 5.03M | 21.0M |
| Shareholders' Equity | -23.6K | 451K | 1.13M | 3.83M | 6.66M | 7.84M | 12.1M |
| Cash & Short-term Investments | 13.4K | 412K | 1.15M | 3.33M | 3.98M | 5.40M | 13.0M |
| Total Debt | 24.0K | - | 283K | 210K | - | 2.64M | 12.0M |
| Cash Flow | |||||||
| Operating Cash Flow | -217K | -661K | -1.59M | -4.56M | -5.49M | -5.93M | 0.00 |
| Capital Expenditure | 0.00 | 32.5K | 35.5K | 11.2K | 9.16K | 448K | 968K |
| Free Cash Flow | -217K | -693K | -1.62M | -4.57M | -5.50M | -6.38M | 0.00 |
| Ratios | |||||||
| ROE | - | -174.1% | -159.1% | -112.4% | -93.8% | -98.4% | - |
| ROA | -1,309.5% | -117.8% | -95.1% | -82.9% | -69.4% | -59.9% | - |
| Net Profit Margin | - | -94,889.8% | -234.9% | -251.2% | -253.1% | -1,306.3% | - |
| Debt to Equity | - | - | 0.25x | 0.05x | - | 0.34x | 0.99x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
PMGC Holdings Inc. dividends
PMGC Holdings Inc. has not paid dividends in the last 6 fiscal years.
Last stock split: 1:10 on Aug 21, 2026.
Who owns PMGC Holdings Inc.
- Insiders 5.61%
- Institutions 3.56%
- Public & others 90.83%
- Shares outstanding 810K
- Free float 764K
Top funds holding ELAB.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Fidelity Extended Market Index | 4.64K | 0.57% | 0.00% | Sep 2026 |
| Fidelity Series Total Market Index | 900.00 | 0.11% | 0.00% | Sep 2026 |
| Fidelity Total Market Index | 378.00 | 0.05% | 0.00% | Sep 2026 |
Top institutions holding ELAB.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Jane Street Group LLC | 81.5K | 1.01% | +157.96% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 53.0K | 0.65% | +253.33% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 34.0K | 0.42% | 0.00% | Jun 2026 |
| Geode Capital Management, LLC | 24.1K | 0.30% | 0.00% | Jun 2026 |
| Vanguard Capital Management, LLC | 16.7K | 0.21% | 0.00% | Jun 2026 |
| Virtu Financial LLC | 16.6K | 0.21% | 0.00% | Jun 2026 |
| XTX Topco Ltd | 14.1K | 0.17% | 0.00% | Jun 2026 |
| Tower Research Capital LLC | 2.51K | 0.03% | +1,841.86% | Jun 2026 |
| UBS Group AG | 2.35K | 0.03% | +80.65% | Jun 2026 |
| IFP Advisors, LLC | 1.00K | 0.01% | -50.00% | Jun 2026 |
| Danske Bank A/S. | 1.00 | 0.00% | 0.00% | Jun 2026 |
| Schonfeld Strategic Advisors LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
PMGC Holdings Inc. company profile
- Company name
- PMGC Holdings Inc.
- Ticker
- ELAB.US
- Exchange
- USA Stocks
- Listed since
- Nov 21, 2023
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 32
- Fiscal year end
- December
- Address
- 120 Newport Center Drive, Newport Beach, CA, United States, 92660
- Phone
- 866 445 4886
- Website
- pmgcholdings.com
About PMGC Holdings Inc.
PMGC Holdings Inc., doing business as NorthStrive Holdings, Inc, a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
PMGC Holdings Inc. management
1- Mr. Graydon Bensler C.F.A.CEO, CFO, Secretary & Director · born 1992